Correlation of IL-1alpha and IL-4 gene polymorphisms and clinical parameters in idiopathic pulmonary fibrosis
Language English Country Great Britain, England Media print
Document type Journal Article, Research Support, Non-U.S. Gov't
PubMed
17309781
DOI
10.1111/j.1365-3083.2007.01896.x
PII: SJI1896
Knihovny.cz E-resources
- MeSH
- Bronchoalveolar Lavage Fluid cytology MeSH
- Adult MeSH
- Genetic Predisposition to Disease * MeSH
- Genotype MeSH
- Interleukin-1alpha genetics MeSH
- Interleukin-4 genetics MeSH
- Middle Aged MeSH
- Humans MeSH
- Pulmonary Fibrosis genetics MeSH
- Tomography, X-Ray Computed MeSH
- Polymerase Chain Reaction MeSH
- Polymorphism, Genetic * MeSH
- Promoter Regions, Genetic MeSH
- Respiratory Function Tests MeSH
- Aged, 80 and over MeSH
- Aged MeSH
- Vital Capacity MeSH
- Check Tag
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Aged, 80 and over MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Names of Substances
- Interleukin-1alpha MeSH
- Interleukin-4 MeSH
Idiopathic pulmonary fibrosis (IPF) is a serious disease characterized with progressive scarring of the lungs in which a genetic background is supposed. We have tested correlation of promotor regions of IL-1alpha and IL-4 gene polymorphisms with clinical parameters in IPF. We investigated the group of 30 patients with IPF. The correlations of vital capacity (VC) and diffusing capacity for carbon monoxide (DL(CO)), bronchoalveolar lavage (BAL) fluid cell counts and high resolution computed tomography (HRCT) alveolar and interstitial scores with different genotypes of IL-4 at (-1098), (-590) and (-33) positions and IL-1 alpha at (-889) position were tested. The PCR method was used for genotyping. The carriers of CT genotype at IL-1 alpha (-889) position had higher VC at the time of diagnosis. The CC genotype at this position was more frequent in patients with higher counts of HLADR+ T lymphocytes in BAL. The GT genotype at IL-4 (-1098) position correlated with higher counts of CD4(+) T lymphocytes, and inversely the TT genotype with higher counts of CD8(+) T lymphocytes in BAL fluid. According to dynamic changes of HRCT score the CT genotype at IL-4 (-33) was more frequent in patients with progressive disease compared to that with stable disease. We assume from our data that the gene polymorphisms of the promotor region of IL-4 at position (-1098) and (-33) and IL-1 alpha at position (-889) are likely to play a pathogenic role in IPF and in modification of its clinical presentation and severity.
References provided by Crossref.org